BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9255426)

  • 1. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
    Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
    Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
    Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
    Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
    Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
    J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers.
    Okumura S; Fukuda Y; Takahashi K; Fujita T; Yamamoto A; Muranishi S
    Pharm Res; 1996 Aug; 13(8):1247-51. PubMed ID: 8865321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
    Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the promotion mechanism of the colonic absorption of antipyrine, phenol red and cefmetazole.
    Shiga M; Hayashi M; Horie T; Awazu S
    J Pharm Pharmacol; 1987 Feb; 39(2):118-23. PubMed ID: 2881996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
    Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
    Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
    Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
    J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.
    Gotoh S; Nakamura R; Nishiyama M; Quan YS; Fujita T; Yamamoto A; Muranishi S
    J Pharm Sci; 1996 Aug; 85(8):858-62. PubMed ID: 8863277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights.
    Morita T; Yamamoto A; Hashida M; Sezaki H
    Biol Pharm Bull; 1993 Mar; 16(3):259-62. PubMed ID: 7689890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
    Fetih G; Habib F; Okada N; Fujita T; Attia M; Yamamoto A
    J Control Release; 2005 Sep; 106(3):287-97. PubMed ID: 15982776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.
    Morishita M; Morishita I; Takayama K; Machida Y; Nagai T
    Biol Pharm Bull; 1993 Jan; 16(1):68-72. PubMed ID: 7690292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique.
    Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1994 Feb; 17(2):316-22. PubMed ID: 7515747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal absorption of raltitrexed and evaluation of the effects of absorption enhancers.
    Yu Y; Lu Y; Zhao X; Li X; Yin Z
    Pharmazie; 2013 Sep; 68(9):732-43. PubMed ID: 24147341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
    Higaki K; Yata T; Sone M; Ogawara K; Kimura T
    Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic transfer of macromolecules after intrapulmonary administration in the presence or absence of various absorption enhancers in rats.
    Muranishi S; Fujita T; Murakami M; Yamamoto A
    Pharmazie; 1996 May; 51(5):331-6. PubMed ID: 8710955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular weight-dependent lymphatic transfer of fluorescein isothiocyanate-labeled dextrans after intrapulmonary administration and effects of various absorption enhancers on the lymphatic transfer of drugs in rats.
    Hanatani K; Takada K; Yoshida N; Nakasuji M; Morishita Y; Yasako K; Fujita T; Yamamoto A; Muranishi S
    J Drug Target; 1995; 3(4):263-71. PubMed ID: 8821000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
    Onishi H; Imura Y; Uchida M; Machida Y
    Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method.
    Watanabe E; Takahashi M; Hayashi M
    Eur J Pharm Biopharm; 2004 Nov; 58(3):659-65. PubMed ID: 15451542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.